Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Accenture
Deloitte
Baxter
Boehringer Ingelheim
Healthtrust
Dow
Daiichi Sankyo
McKesson

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040101

« Back to Dashboard
NDA 040101 describes PROCHLORPERAZINE MALEATE, which is a drug marketed by Sandoz, Duramed Pharms Barr, Teva Pharms, Ivax Sub Teva Pharms, and Mylan, and is included in eight NDAs. It is available from twenty suppliers. Additional details are available on the PROCHLORPERAZINE MALEATE profile page.

The generic ingredient in PROCHLORPERAZINE MALEATE is prochlorperazine maleate. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

Summary for NDA: 040101

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040101

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 040101

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCHLORPERAZINE MALEATE
prochlorperazine maleate
TABLET;ORAL 040101 ANDA Sandoz Inc 0781-5020 0781-5020-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-5020-01)
PROCHLORPERAZINE MALEATE
prochlorperazine maleate
TABLET;ORAL 040101 ANDA Sandoz Inc 0781-5020 0781-5020-05 500 TABLET, FILM COATED in 1 BOTTLE (0781-5020-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Jul 19, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Jul 19, 1996TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 25MG BASE
Approval Date:Jul 19, 1996TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Citi
Teva
Chinese Patent Office
Fish and Richardson
Fuji
Novartis
Cerilliant
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot